Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)

Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI) Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-β type I receptor (ALK5) inhibitors Discovery of a novel protein kinase B inhibitor by structure-based virtual screening Discovery of TRAF-2 and NCK-interacting kinase (TNIK) inhibitors by ligand-based virtual screening methods Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors Shape-Based Reprofiling of FDA-Approved Drugs for the H₁ Histamine Receptor Design, Synthesis, and Evaluation of Indolinones as Inhibitors of the Transforming Growth Factor β Receptor I (TGFβRI) 3D pharmacophore based virtual screening of T-type calcium channel blockers Discovery of new acetylcholinesterase inhibitors with small core structures through shape-based virtual screening Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations